Merck: Navigating Patent Cliff and Growth Prospects
Merck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
When To Choose A Benchmark Over A Strategic Index explains decision points for selecting benchmarks based on goals, cost, and risk tolerance.
25,499 articlesMerck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
June’s stock market today saw Robinhood rise on the heels of an IPO underwriting announcement, signaling a potential ...
Alphabet’s billion flex is more than just cash. It’s a strategic playbook that powers buybacks, AI investments, and l...
Investors are watching novavax (nvax) 2025 earnings closely as the company pivots its vaccine portfolio. This article...
UWM Holdings said its controlling shareholder terminated a rules-based stock-sale program intended to boost float and...
A major asset sale could recalibrate FMC’s balance sheet and growth trajectory. This guide breaks down what the deal ...
GameStop's Ryan Cohen signals a continued bid to acquire eBay despite board pushback, detailing strategy, financing, ...
A surprise leadership change jolted Copart’s stock, sparking an intraday drop. This article breaks down the why, what...
Insider moves can reveal much about a company’s outlook, but they aren’t a single data point. This article breaks dow...
BitGo's latest move adds to the crypto job-cut trend as it slashes about 15% of its workforce to refocus on stablecoi...
A major stake from Nvidia lit a fire under Nebius Group, sending Nebius stock soared today. Here's what this means fo...
As Liquidia releases its Q4 2025 results, investors crave clarity on revenue, burn rate, and milestones. This article...